Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9236)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 15, 2016 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kourie HR, Gharios J, Elkarak F, Antoun J, Ghosn M. Is metastatic pancreatic cancer an untargetable malignancy? World J Gastrointest Oncol 2016; 8(3): 297-304 [PMID: 26989465 DOI: 10.4251/wjgo.v8.i3.297] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i3/297.htm |
| Number | Citing Articles |
| 1 |
Qiangsheng Hu, Yi Qin, Bo Zhang, Chen Liang, Shunrong Ji, Si Shi, Wenyan Xu, Jinfeng Xiang, Dingkong Liang, Quanxing Ni, Xianjun Yu, Jin Xu. FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1. Oncology Reports 2017; 38(4): 2069 doi: 10.3892/or.2017.5856
|
| 2 |
Qingcai Meng, Si Shi, Chen Liang, Dingkong Liang, Jie Hua, Bo Zhang, Jin Xu, Xianjun Yu. Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling. Oncogene 2018; 37(44): 5843 doi: 10.1038/s41388-018-0392-z
|
| 3 |
FERMÍN MAR-AGUILAR, CRISTINA RODRÍGUEZ-PADILLA, DIANA RESÉNDEZ-PÉREZ. Web-based tools for microRNAs involved in human cancer. Oncology Letters 2016; 11(6): 3563 doi: 10.3892/ol.2016.4446
|
| 4 |
Elzbieta Nowara, Joanna Huszno. Masitinib plus gemcitabine for personalized treatment of PDAC patients with overexpression of ACOX1. Expert Review of Precision Medicine and Drug Development 2016; 1(6): 479 doi: 10.1080/23808993.2016.1257911
|
| 5 |
Jeffrey Q. Nguyen, Rosalyn B. Irby. TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells. Cancer Biology & Therapy 2017; 18(1): 16 doi: 10.1080/15384047.2016.1252880
|
| 6 |
Barbara Grünwald, Jennifer Vandooren, Michael Gerg, Kaarin Ahomaa, Annique Hunger, Sonja Berchtold, Sophia Akbareian, Susanne Schaten, Percy Knolle, Dylan R. Edwards, Ghislain Opdenakker, Achim Krüger. Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow. Molecular Cancer Research 2016; 14(11): 1147 doi: 10.1158/1541-7786.MCR-16-0180
|
| 7 |
Marwan Ghosn, Tony Ibrahim, Tarek Assi, Elie El Rassy, Hampig Raphael Kourie, Joseph Kattan. Dilemma of first line regimens in metastatic pancreatic adenocarcinoma. World Journal of Gastroenterology 2016; 22(46): 10124-10130 doi: 10.3748/wjg.v22.i46.10124
|
| 8 |
Abdel Hadi Hajjar, Roland Eid, Fady Gh Haddad, Hampig Raphael Kourie. FOLFIRINOX: a new standard of care in the adjuvant setting of resectable pancreatic adenocarcinomas. Future Oncology 2019; 15(17): 1947 doi: 10.2217/fon-2019-0136
|